Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DL-alanine for primary sclerosing cholangitis
jRCTs031230676Recruiting
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of l-alanine in Primary Sclerosing Cholangitis (PSC) and autoimmune colitis. Primary endpoint: Percentage change of serum ALP levels. Started Mar 2024; status: recruiting.
02
Drugs
l-alanine
03
Conditions
Primary Sclerosing Cholangitis (PSC)autoimmune colitis
Beyond the preview
Go deeper on jRCTs031230676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230676.